Axon Enterprise vs Smith & Wesson Brands
AXON and SWBI side by side, both in fabricated metal products, except machinery and transportation equipment. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How AXON and SWBI compare
Axon Enterprise is the larger company, worth 57 times as much as Smith & Wesson Brands ($34.8B against $613M).
Axon Enterprise grew revenue faster over the last twelve months (34.6% versus 17.0% for Smith & Wesson Brands).
Axon Enterprise keeps more of each dollar of sales as profit, with a net margin of 6.2% compared with 4.4% at Smith & Wesson Brands.
Smith & Wesson Brands pays a dividend yielding 3.8%; Axon Enterprise does not pay one.
Smith & Wesson Brands scores higher on the StockData Score (15 against 6 for Axon Enterprise), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | AXON | SWBI |
|---|---|---|
| Size and price | ||
| Market cap | $34.8B | $613M |
| Share price | $427.77 | $13.66 |
| Change, 1 year | −43.7% | 35.0% |
| Change, 5 years | 134% | −37.9% |
| Beta (5Y) | 1.49 | 0.84 |
| Employees | 5,100 | 46 |
| StockData Score | ||
| Total score | 6 | 15 (better) |
| Valuation score | 0 | 2 (better) |
| Growth score | 3 | 3 |
| Performance score | 1 | 1 |
| Health score | 2 | 6 (better) |
| Dividend score | 0 | 3 (better) |
| Valuation | ||
| P/E | 177× | – |
| P/S | 10.8× | 1.1× (better) |
| P/B | 9.5× | 1.6× (better) |
| EV/EBITDA | 269× | 8.9× (better) |
| P/FCF | 261× | 7.5× (better) |
| FCF yield | 0.38% | 13.4% (better) |
| Fair value | $74.82 | $14.41 |
| Margin of safety | −472% | 5.2% (better) |
| Growth | ||
| Revenue growth (TTM) | 34.6% (better) | 17.0% |
| Revenue growth, 5Y average | 32.5% (better) | −13.1% |
| Net income growth (TTM) | −38.9% | 106% (better) |
| EPS growth (TTM) | −40.3% | – |
| EPS growth, 5Y average | – | −38.2% |
| Profitability | ||
| Gross margin | 59.4% (better) | 27.4% |
| Operating margin | 0.74% | 6.6% (better) |
| Net margin | 6.2% (better) | 4.4% |
| FCF margin | 4.1% | 14.9% (better) |
| Return on equity | 6.2% | 6.6% (better) |
| Return on invested capital | 0.65% | 7.7% (better) |
| Financial health | ||
| Debt / equity | 0.47 (better) | 0.00 |
| Net debt / EBITDA | 7.81 | – |
| Interest coverage | 0.2× | – |
| Current ratio | 2.15 | 3.62 (better) |
| Altman Z-score | 6.39 (better) | 5.14 |
| Piotroski F-score | 6 | 7 (better) |
| Dividends and buybacks | ||
| Dividend yield | – | 3.8% |
| Payout ratio | – | 95.3% |
| Years of dividend growth | – | 0 |
| Shareholder yield | 0.00% | 3.8% (better) |
| Ownership | ||
| Held by institutions | 89.1% | 64.8% |
| Held by insiders | 5.4% | 3.4% |
| Insider net buying, 12 months | −$130M | – |
| Short interest, % of float | 5.1% | 5.2% |
Go deeper
- AXON stock overview
- AXON income statement
- AXON valuation and score
- SWBI stock overview
- SWBI income statement
- SWBI valuation and score
For information only, not investment advice. Check the source filings before relying on any figure.